Woodford Patient Capital Share Discussion Threads

[1tcm1] 23/5/2018 08:41

Yes die, die, all you horrible Woodford supporters. I really hate that guy. You probley did not realise that.

[jonwig] 23/5/2018 05:53

Charles Stanley Direct has dropped Neil Woodford's flagship income fund from its best buy list, flagging concerns over the manager's investment in early-stage companies.

[costax1654x] 22/5/2018 19:52

Guys have a look at Aeg as well.Last RNS was amazing.Potential multibag in 2018.Take care

[topvest] 22/5/2018 19:52

Equity Income Fund ups its debt level to £170m! headline.

[daffyjones] 22/5/2018 19:05

The equity income fund doesn't have any debt? I thought we'd covered this. It's only the close ended WPCT that is geared AFAIK

[topvest] 22/5/2018 18:02

See Charles Stanley has now stopped recommending Woodford. Very diplomatic story on Citywire, but I’m sure they are not the last platform to avoid the toxic recommendation before they get legal letters (when it all goes pear shaped). Anyone seen how much debt the Equity Income Fund is now holding at the end of April? Eye watering debt levels for an open ended fund which are normally unlevered. If this is what’s happening at the end of a very long bull market where it’s pretty much impossible to lose money, it doesn’t take an Einstein to work out what’s going to happen when the technology bull market corrects, as it surely will.

[chuckol] 22/5/2018 15:55

See you on the Croisette in October, Malcolm. Hip Hip

We dished you jacks good and proper, didn't we?

[solonic] 22/5/2018 15:29

Yet another. Yawn........

[mip55] 22/5/2018 14:24

Thanks jonwigCircassia was at one time a top 10 holding in Woodford's Patient Capital Trust but he shifted it into his Equity Income fund last August at a time when he was increasing Patient Capital's exposure to riskier unquoted stocks.

[jonwig] 22/5/2018 12:54

@ mip55 - Not in WPCT:



Maybe elsewhere?

[mip55] 22/5/2018 12:03

Positive RNS this morning from Circassia ( if we still retain an interest in it after the allergy debacle)Steve Harris, Circassia's CEO, said: "With both the ASCENT and AMPLIFY studies meeting their primary endpoints, the positive data presented at the American Thoracic Society conference are highly supportive for Tudorza® and Duaklir®. As a result, we look forward to regulatory filings in the coming weeks seeking US approval for Duaklir® and an extension to Tudorza®'s US prescribing information to include the ASCENT data."

[topvest] 20/5/2018 19:26

Ocado was too close to profit to be of interest to such a genius. He likes cash guzzlers, with no revenue but blue sky prospects. Otherwise known as story stocks or sucker stocks.

[ltcm1] 20/5/2018 19:24

But in 2015 Ocado had full listing and a track record. It seems strange he passed on what would have been a liquid stake in a top UK disrupter that despite the City cynicism had a credible management and a strategy to make profits.

Hard to understand why Woodford threw his money at a plastic pallets startup and ignored a business that had been trading 10 years.

In Woodford we trust???

[topvest] 20/5/2018 18:48

I think it’s simple. Woodford likes to take big stakes (about 30%.) and be one of the main investors. He couldn’t do that on Ocado which has been going for well over 10 years or so. All of these so called disrupters / certainly most of them are massively overvalued. That’s what you get near the top of a bull market. It’s also pretty much a gamble picking early stage winners. It’s closer to speculation rather than investing, but it takes a bear market to figure out that this time it’s not different!

Ocado have just delivered my order on time, with no substitutes and 37% off the normal price. Quality! Mind you I’ve no idea how they make a profit. Delivery is also free of course.

[ltcm1] 20/5/2018 18:17

And yet Ocado could still be cheap, they have better robotics than Amazon reputedly and hold 20 patents. They could have huge demand as retailers clamour to negate the Amazon threat.

Ofcourse I do not know the answer to the Ocado valuation question. But regardless of whether it comes good or not, it is very odd Mr Woodford did not invest in 2015 as it had all the hallmarks of a disruptor and is arguably one of the UK's best chances in the field.

Definitely a question for Awkward Corner if Woody hadn't closed it down.

[topvest] 20/5/2018 17:20

Presumably because he missed the boat. He splurged the cash in a couple of years. I'm pleased for Ocado though as they are a good web retailer - actually the best for home delivery by a long way. Looks way over valued now and the shorts have been badly burnt which is amusing and shows the risk of shorting. Just because something is expensive and overvalued, doesn't mean that it can't be twice as expensive and overvalued with a bit of good news and a short squeeze.

[ltcm1] 20/5/2018 10:35

WPCT is supposed to be not just biotech but disruptors also. Then why didn't Woodford invest in Ocado for goodness sake???